Amine headgroups in ionizable lipids drive immune responses to lipid nanoparticles by binding to the receptors TLR4 and CD1d
Namit Chaudhary(Scripps Research Institute), Kathryn A. Whitehead(Carnegie Mellon University), Mariah L. Arral(Carnegie Mellon University), Sushant Kumar(Yale University), Samuel T. LoPresti(Carnegie Mellon University), Lisa N. Kasiewicz(Eli Lilly (United States)), Saigopalakrishna S. Yerneni(Carnegie Mellon University), Alexandra N. Newby(Carnegie Mellon University), Daria M. Strelkova Petersen(Carnegie Mellon University), Jilian R. Melamed(Kaiser Permanente), Katherine C. Fein(Carnegie Mellon University), Rahul Purwar(Indian Institute of Technology Bombay)
Cited by 107
Related Papers
Knocking down barriers: advances in siRNA delivery
|Nature Reviews Drug Discovery|2009|3.1k
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
|Nature Reviews Drug Discovery|2021|1.5k
Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity
|Nature Communications|2014|628
Managing diabetes with nanomedicine: challenges and opportunities
|Nature Reviews Drug Discovery|2014|608
The replacement of helper lipids with charged alternatives in lipid nanoparticles facilitates targeted mRNA delivery to the spleen and lungs
|Journal of Controlled Release|2022|270